 |
Quick Links |
| Information by Disease |
|
|
|
| Cancer News |
|
|
|
| Conference Coverage |
|
|
|
| AZN | $44.39 | 0.08 (0.18%)
| | NVS | $54.86 | 0.08 (0.15%)
| | SNY | $39.44 | 0.88 (2.28%)
| | GSK | $37.79 | 0.06 (0.16%)
|
|
|
|
|
|
Treating Malignant Disease With Reduced Intensity Stem Cell Transplants - A Review (12/1/2005)
By C. Dean Buckner, MD
December 2005
Rethinking Allogeneic Stem Cell Transplants for Chronic Myeloid Leukemia in the Gleevec® Era (11/16/2005)
By C. D. Buckner, MD
November 2005
Allogeneic Stem Cell Transplantation for Multiple Myeloma (10/28/2005)
By William I. Bensinger, MD, Professor, University of Washington; Member, Fred Hutchinson Cancer Research Center
November 2005
Advances in the Prevention and Management of Oral Mucositis (3/4/2005)
Oncology nurses are at the forefront of delivering the bulk of the treatment and care required by cancer patients. Among their many responsibilities, oncology nurses play a critical role in the prevention, identification, and management of side effects, including oral mucositis.
Medical Genomics: Implications for Clinical Oncology (5/27/2004)
By Charles H. Weaver, MD, and Dayna Deuter
January 2005
The Role of Erythropoietic Agents in Managing the Anemia of Cancer (5/27/2004)
By Robert E. Smith, Jr., MD, South Carolina Oncology Associates, PA
January 2005
Antisense Therapy: An Overview (5/24/2004)
Jenny Maxon, RN and Charles H. Weaver, MD
January 2005
 |
 Newsletters |
 |
|
 |
Register in our member center today to receive a monthly newsletter with current topic updates.
Learn More »
|
|
|
 |
|
 |
|
Practice Resources |
|
|
 |
Learn how to have our current topics on your website.
Learn More »
|
|
|
|
|
|
|
|
|
| This content made available by an unrestricted grant from: |
|
|
|
 |
Coming Soon |
|
Chemotherapy Induced Anemia: An Update on Management Strategies
|
|
|
|
|
 Information by Cancer Type |
|
|
|
|
|
|
|
|
Patient Home
